MedTrace Logo

Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.

NCT03564665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-04-12

No results posted yet for this study

Summary

The goal of this study is to further evaluate the effect of magnesium on the symptoms of menopause, specifically vasomotor symptoms (VMS) in breast cancer patients and/or women at an elevated risk of breast cancer.

Conditions

Interventions

DIETARY_SUPPLEMENT

400mg Magnesium Glycinate BID

400mg Magnesium Glycinate BID for 8 weeks.

OTHER

Placebo

Placebo BID for 8 weeks.

Sponsors & Collaborators

Principal Investigators

  • Dawn M Mussallem · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-24
Primary Completion
2021-04-10
Completion
2021-04-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564665 on ClinicalTrials.gov